BDBM328833 (S)-tert-butyl (4-((4-fluoro-3- methoxyphenyl)sulfonyl)-2- (methylsulfonamidomethyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US9663502, 37C

SMILES COc1cc(ccc1F)S(=O)(=O)N1C[C@H](CNS(C)(=O)=O)Oc2ccc(NC(=O)OC(C)(C)C)cc12

InChI Key InChIKey=ZYYPTIHTKYZJEE-HNNXBMFYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 328833   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Lycera

US Patent
LigandPNGBDBM328833((S)-tert-butyl (4-((4-fluoro-3- methoxyphenyl)sulf...)
Affinity DataIC50:  4.09nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., a biochemical TR-FRET assay....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent